Concepedia

Joel Desharnais

JD

Statistics

Publications

10

Citations

735

H-Index

10

Active since

2001

Affiliations

Scripps Research Institute(Current)

Pennsylvania State University

Pfizer (United States)

Joel Desharnais is an author at Scripps Research Institute specializing in medicine, drug discovery, and natural sciences.

Top concepts

MedicineBiochemistryDrug DiscoveryNatural SciencesPharmacologyImmunologyCell BiologyImmunotherapyChemical BiologyProtein Engineering

Publications per year

2001–2016

10

Publications

10

Small-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblasts

Thorsten Berg, Steven B. Cohen, Joel Desharnais et al. · Proceedings of the National Academy of Sciences · 2002 · 323 citations · Full text

Chemical generation of bispecific antibodies

Venkata Ramana Doppalapudi, Jie Huang, Dingguo Liu et al. · Proceedings of the National Academy of Sciences · 2010 · 124 citations · Full text

Biochemistry, Scaffold Antibody, Chemical Generation +15

Erythropoietin Mimetics Derived from Solution Phase Combinatorial Libraries

Joel Goldberg, Qing Jin, Yves Ambroise et al. · Journal of the American Chemical Society · 2001 · 67 citations

Biomedical Engineering, Medicinal Chemistry, Receptor Tyrosine Kinase +16

Inhibiting complex IL-17A and IL-17RA interactions with a linear peptide

Shenping Liu, Joel Desharnais, Parag V. Sahasrabudhe et al. · Scientific Reports · 2016 · 55 citations · Full text

Rational Design, Synthesis, Evaluation, and Crystal Structure of a Potent Inhibitor of Human GAR Tfase: 10-(Trifluoroacetyl)-5,10-dideazaacyclic-5,6,7,8-tetrahydrofolic Acid<sup>,</sup>

Yan Zhang, Joel Desharnais, Thomas H. Marsilje et al. · Biochemistry · 2003 · 46 citations

1–5 of 10